Abstract:The tumor is a complex system composed of various elements, encompassing cells, extracellular matrix, and the tumor microenvironment. Each of these distinct factors plays a pivotal role in the development and progression of tumors. The specific analysis of tumor-associated cells, extracellular matrix, and tumor microenvironment is of paramount importance for precise diagnosis and targeted therapy of tumors. Peptide probes have gained substantial prominence in investigations focused on tumor-specific imaging, primarily attributed to their notable attributes, including high specificity, biocompatibility, tissue-penetrating capabilities, and straightforward preparation processes. This review comprehensively summarizes the peptide probes for specific imaging of tumor-associated cells. The specific recognition of cells was by binding various cellular markers, such as the epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), and folate receptor (FR alpha) for tumor cells. Additionally, the biomarkers include CD206, neurokinin-1 receptor (NK-1R), and CD11c for immune cells, along with nucleolin and integrins for tumor vascular endothelial cells. Furthermore, this comprehensive review encapsulates peptide probes designed for the specific targeting of extracellular matrix proteins and their applications in tumor-specific imaging. The focal points among these protein targets encompass pathological collagen, matrix metalloproteinases, and fibronectin. Of particular significance is the potential of pathological collagen as a highly promising extracellular matrix target for achieving tumor-specific imaging. The review comprehensively outlines tumor-specific peptide probes responsive to various factors within the tumor microenvironment. Commonly encountered responsive factors in the tumor microenvironment include mild acidity (pH), heightened enzyme activity, such as matrix metalloproteinases and cathepsin, and elevated levels of oxidative stress. It further explores their versatile applications in bioimaging. Lastly, this review discusses the clinical applications of tumor-specific peptide probes in diagnostic practices. It explores the current challenges and prospects of these peptide probes, elucidating their potential contributions to precision diagnosis and personalized treatment of tumors, including precise surgical navigation and their synergistic use with immunotherapy.

Progress of New Strategies on Screening of Targeting Peptides and Applications in Tumor Immunotherapy

Peptide-Based Nanomaterials for Tumor Immunotherapy

Research Progress on Tumor-Targeting Immunoconjugate

Applications of Peptide-based Nanomaterials in Targeting Cancer Therapy

Immunomodulatory Peptides for Tumor Treatment

Tumor-Targeting Peptides: Ligands for Molecular Imaging and Therapy

Studies on Stimulus Responsive Peptides and Their Applications in Tumor Diagnosis and Treatment

Peptide-Derived Biosensors and Their Applications in Tumor Immunology-Related Detection

Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges

Peptide-Based Treatment: A Promising Cancer Therapy

Peptide-Based Strategies for Targeted Tumor Treatment and Imaging

Polypeptides-Based Nanocarriers in Tumor Therapy

Progress of Molecular Imaging-guided Tumor Immunotherapy

Research Progress on Peptides As Antitumor Agent

Peptide-Mediated Tumor-Targeted Diagnosis and Therapy

Research Progress of Aptamer-mediated Tumor Immunotherapy

Research Progress in Tumor Targeted Immunotherapy

Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect

Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy

Peptide Therapeutics and Assemblies for Cancer Immunotherapy

Tumor-specific Peptide Probes and the Applications in Bioimaging